[1] 中华人民共和国国家卫生健康委员会医政医管局. 《新型冠状病毒肺炎诊疗方案(试行第九版)》修订要点.http://www.nhc.gov.cn/yzygj/s7653p/202203/a354cb3151b74cfdbac6b2e909f311e6.shtml
[2] Madhi SA, Kwatra G, Myers JE, et al. Population Immunity and COVID-19 Severity with Omicron Variant in South Africa. N Engl J Med,2022.
[3] Hammond J, Leister-Tebbe H, Gardner A, et al. Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with COVID-19. N Engl J Med,2022.
[4] Andreani J, Hoang VT, Grimaldier C, et al. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards. Eur J Clin Microbiol Infect Dis,2020,39:1059-1061
[5] Young BE, Ong SWX, Ng LFP, et al. Singapore 2019 Novel Coronavirus Outbreak Research Team. Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity. Clin Infect Dis,2021,73:e2932-e2942.
[6] Rhee C, Kanjilal S, Baker M, et al. Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation? Clin Infect Dis,2021,72:1467-1474. |
